Sophia Liff Maibom
Papers
5
Total Citations
76
H-Index
3
About
Sophia Liff Maibom is a leading clinical researcher in urologic oncology, specializing in the surgical management of bladder cancer. Her work centers on comparing open versus robot-assisted radical cystectomy (RC), with a major focus on rigorous, double-blinded trial design—a rare and methodologically challenging approach in surgical research. As lead author of the landmark BORARC feasibility study (2021, 41 citations), she demonstrated that patients and care providers can be effectively blinded to surgical technique, setting a new standard for unbiased outcomes assessment. Her subsequent work has explored quality of life, haemodynamic and respiratory parameters, and acute kidney injury following RC. Her 2023 study on AKI incidence and risk factors (6 citations) provides critical insights for perioperative care. Collectively, her research has accumulated over 75 citations, advancing evidence-based decision-making in bladder cancer surgery. Maibom’s contributions are particularly notable for their methodological rigor—her double-blinded trials address long-standing questions about the true benefits of robotic surgery, making her a key voice in the ongoing debate over surgical innovation versus established techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5